Final answer:
High entry barriers due to stringent FDA regulations lead to increased safety for consumers but can make it more challenging for new companies to enter the pharmaceutical industry and for patients to quickly access new treatments.
Step-by-step explanation:
The student's question relates to the impact of FDA regulations on the attractiveness of the pharmaceutical industry. High entry barriers set by stringent FDA regulations are often seen as a deterrent to new companies entering the market. This is because the process of bringing a new drug to market can be incredibly costly and time-consuming, often requiring years of testing to ensure safety and efficacy. However, this perspective does not consider that these regulations also protect consumers from unsafe and ineffective drugs.
While it is true that pharmaceutical companies face significant challenges due to these regulations, calling the industry 'unattractive' might be subjective and oversimplified. The barriers to entry created by FDA regulations ensure a higher standard of public health protection and contribute to the overall credibility of the pharmaceutical market. Those who suffer from such regulations are often smaller, newer companies that may not have the resources to meet the stringent requirements. Furthermore, patients who might benefit from innovative treatments might experience delayed access due to the lengthy approval process.